UBS published a report stating that CSPC PHARMA (01093.HK) recorded revenue of RMB6.5 billion in 1Q26, down 7.8% YoY, exceeding both the bank s and market expectations. Net profit ... Open a new ...
On Tuesday, CSPC Pharmaceutical Group Ltd. (1093:HK) (OTC: CHJTF), a pharmaceutical company with nearly $4 billion in annual revenue and an impressive 70% gross margin, received an upgraded stock ...
License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom) Combining Rezdiffra with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results